Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT00902109
Other study ID # SCOPE-G-BETA
Secondary ID
Status Active, not recruiting
Phase N/A
First received May 12, 2009
Last updated January 31, 2016
Start date April 2010
Est. completion date December 2016

Study information

Verified date January 2016
Source University Hospital Tuebingen
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Observational

Clinical Trial Summary

The purpose of this study is to compare the two psychophysical perimetric techniques regarding progression of the visual field.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 12
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- primary open angle glaucoma (POAG)

- spherical ametropia max. ± 8 dpt

- cylindrical ametropia max. ± 3 dpt

- distant visual acuity > 10/20

- pupil diameter > 3 mm

Exclusion Criteria:

- diabetic retinopathy

- asthma

- history of epilepsy or significant psychiatric disease

- medications known to effect visual field sensitivity

- infections (e.g., keratitis, conjunctivitis, uveitis)

- severe dry eyes

- miotic drug

- squint

- nystagmus

- albinism

- any ocular pathology, in either eye, that may interfere with the ability to obtain visual fields

- keratoconus

- intraocular surgery (except for uncomplicated cataract surgery) performed < 3 month prior to screening

- history or signs of any visual pathway affection other than glaucoma

- history or presence of macular disease and/or macular edema, ocular trauma, medications known to affect visual field sensitivity

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
Perimetry
different perimetric devices, different perimetric grids: Octopus: New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) HFA: 30-2, Sita (Swedish Interactive Thresholding Algorithm) full threshold
Confocal Scanning Laser Tomography
HRT examinations for the clinical evaluation of the optic disc.
Optical Coherence Tomography (OCT)
imaging of the retinal nerve fiber layer

Locations

Country Name City State
Germany Institute for Ophthalmic Research Tuebingen

Sponsors (2)

Lead Sponsor Collaborator
University Hospital Tuebingen Alcon Research

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Schiefer U, Pascual JP, Edmunds B, Feudner E, Hoffmann EM, Johnson CA, Lagrèze WA, Pfeiffer N, Sample PA, Staubach F, Weleber RG, Vonthein R, Krapp E, Paetzold J. Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies. Invest Ophthalmol Vis Sci. 2009 Jan;50(1):488-94. doi: 10.1167/iovs.08-2229. Epub 2008 Dec 5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of rate of progression Perimetric measures every 3 month over 3 years 36 month No
See also
  Status Clinical Trial Phase
Completed NCT01085357 - Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery N/A
Completed NCT02434692 - Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG) N/A
Completed NCT02700984 - A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial N/A
Recruiting NCT06016972 - Qlaris Phase 2 Study of QLS-111 in POAG and/or OHT Patients Phase 2
Completed NCT01517477 - One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects N/A
Terminated NCT01180062 - Safety Study of Latanoprost Slow Release Insert Phase 1
Terminated NCT03478293 - iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications N/A
Completed NCT01166659 - Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy N/A
Completed NCT01252849 - Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects N/A